Annalisa Capuano is a Full Professor in Pharmacology at the University of Campania “Luigi Vanvitelli” and she is head of the Regional Center for Pharmacovigilance and Pharmacoepidemiology of the Campania region, which is at the Department of Experimental medicine of the same University. Since 2008, she is a member of the Pharmacovigilance Secretariat of Italian Medicine Agency (Agenzia Italiana del Farmaco, AIFA) and ENCePP of European Medicine Agency (EMA). As Pharmacologist, she is a member of Ethics Committees of the Campania Region. Since 2014, she participates in the EudraVigilance Clinical Trial module for the electronic reporting of Individual Case Safety Report. Since 2015, she is a member of the section of Clinical Pharmacology of the Italian Society of Pharmacology. Her research activities mainly aim to evaluate the risk-benefit balance of drugs during pre- and post-marketing clinical trials. She has collaborated for many years with the National Institute of Health (Istituto Superiore di Sanità, ISS) and she was a member of the teaching staff of the Erasmus MC Medical Center (Holland). From February 2015 to January 2018, she attended the Cell Sciences Research Institute and the St. George University Hospital in London, where she developed competencies for the conduction of clinical trials, including patient recruitment and management. Since 2019, she is a member of the Executive Committee of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Since 2021, she is a member of the Pharmacovigilance Risk Assessment Committee (PRAC) of the EMA. Since September 2021, she is a member of the Technical-Scientific Commission of the AIFA.
